Brevan Howard Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,780	Closed	-$86.1K	–	1131
2024 Q3	$86.1K	Sell	10,780 -2,781	-21%	-$22.2K	﹤0.01%	1023
2024 Q2	$118K	Buy	+13,561	New	+$118K	﹤0.01%	905